Myopia (short sighted) Clinical Trials Myopia (short sighted) RSS feedThis is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

Low-Dose Atropine Eyedrops No Better Than Placebo for Slowing Myopia Progression
  July 13, 2023 -- Use of low-dose atropine eyedrops (concentration 0.01%) was no better than placebo at slowing myopia (nearsightedness) progression and elongation of the eye among children treated for two years, according to a... (Source: Drugs.com - Clinical Trials)
Source: Drugs.com - Clinical Trials - July 13, 2023 Category: Pharmaceuticals Source Type: clinical trials

Low Concentration Atropine in the Prevention of Myopia in Children.
Condition:   Myopia, Progressive Interventions:   Drug: low concentration atropine (0.01%);   Drug: low concentration atropine (0.02%);   Drug: low concentration atropine (0.04%);   Drug: Placebo Sponsor:   Shanghai Eye Disease Prevention and Treatment Center Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 11, 2023 Category: Research Source Type: clinical trials

Clinical Evaluation of MyoCare in Europe (CEME)
Condition:   Myopia, Progressive Interventions:   Device: MyoCare;   Device: ClearView Sponsors:   Universidad Complutense de Madrid;   Cooperativa de Ensino Superior, Politécnico e Universitário;   Carl Zeiss Meditec, Inc.;   Novovision;   Instituto de Cirugia Ocular;   Miranza Virgen de Lujan;   ICQO Instituto Quirúrgico de Oftalmología;   CPO Clinica Privada d e Oftalmologia, S.A. Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 26, 2023 Category: Research Source Type: clinical trials